Received Jul 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 3 | CD44A | IM / LA |
3RD an final Bexsero to be administered 6 months or after from Day 0, per guidelines. This patient received her first dose on 01/31/25, 2nd dose 03/28/2025 and 3rd dose due on or after 07/31/2025. In this case, Bexsero 3rd dose administered on 07/25/2025, six days prior to recommended dosing schedule. Notified nursing and pharmacist, and requested that the pharmacist reach out to the HCP and notify them of the above.